Related by context. All words. (Click for frequent words.) 74 pamidronate 73 cisplatin chemotherapy 73 radiation chemoradiation 73 postoperative chemotherapy 72 adriamycin 72 pegylated liposomal doxorubicin 72 Doxil ® 71 Gemzar gemcitabine 71 FOLFOX4 71 FUSILEV enhances 71 preoperative chemotherapy 71 mitoxantrone plus 71 adjuvant cisplatin 71 TTF Therapy 71 anthracycline taxane 71 chemoradiation therapy 71 gemcitabine chemotherapy 71 relapsed MM 71 5-fluorouracil/leucovorin 70 carboplatin paclitaxel 70 chemotherapy cisplatin 70 adjuvant radiation 70 Paraplatin ® carboplatin 70 stage IIIb IV 70 Adjuvant chemotherapy 70 temozolomide Temodar 70 Flu Cy 70 Pegylated Interferon 70 Folfox 70 5-FU/LV 70 gemcitabine cisplatin 70 capecitabine Xeloda 70 recurrent metastatic 69 hormone receptor negative 69 FOLFOX6 69 cisplatin gemcitabine 69 fluorouracil leucovorin 69 Temodar ® 69 FOLFIRI alone 69 endocrine therapies 69 paclitaxel Taxol R 69 adjuvant radiotherapy 69 Ceplene/IL-2 69 paclitaxel cisplatin 69 taxane refractory 69 5 fluorouracil leucovorin 69 irinotecan chemotherapy 69 drug Treanda 69 infliximab monotherapy 69 CHOP chemotherapy 69 gemcitabine carboplatin 69 neutropenic sepsis 69 demonstrated antitumor activity 69 cyclophosphamide chemotherapy 69 Cytoxan 69 anastrazole 69 taxotere 69 folinic acid 68 low dose cytarabine 68 irinotecan doxorubicin oxaliplatin paclitaxel 68 unresectable stage 68 maximally tolerated lipid lowering 68 indolent follicular non 68 tamoxifen Nolvadex ® 68 trastuzumab Herceptin ® 68 anthracyclines taxanes 68 iniparib 68 Fludarabine 68 docetaxel Taxotere 68 squamous histology 68 erlotinib Tarceva ® 68 paclitaxel Taxol ® 68 Taxotere docetaxel 68 biochemical relapse 68 debulking surgery 68 metastatic GIST 68 Camptosar ® 68 locoregional recurrence 68 taxane therapy 68 Pemetrexed 68 cyclophosphamide doxorubicin vincristine 68 oblimersen 68 underwent surgical resection 68 metastatic gastric 68 daunorubicin 68 Bevacizumab Avastin 68 Paraplatin ® 68 metastatic pancreatic 68 Caelyx 68 concurrent chemoradiation 68 systemic ALCL 67 unresectable tumors 67 Peginterferon 67 taxane chemotherapy 67 Platinol ® 67 placebo dexamethasone 67 Platinol ® cisplatin 67 5 Fluorouracil 67 TAXOTERE R 67 moderate renal impairment 67 plus prednisone 67 carboplatin chemotherapy 67 paclitaxel chemotherapy 67 chemoradiotherapy 67 interferon alfa 2a 67 letrozole Femara 67 HER2 positive metastatic breast 67 Improved Progression 67 Capecitabine 67 mycophenolate mofetil 67 Roche Herceptin 67 CR nPR 67 ixabepilone 67 cytoreduction 67 anthracycline containing 67 Peg IFN 67 sorafenib Nexavar 67 haematologic 67 5 FU leucovorin 67 Irinotecan 67 doxorubicin cyclophosphamide 67 recurrent glioblastoma multiforme 67 ALIMTA cisplatin 67 chlorambucil 67 fluorouracil 67 temozolomide TMZ 67 estramustine 67 gp# vaccine 67 dasatinib Sprycel 67 baseline LDH 67 metastatic colorectal 67 metastatic bladder 67 mitoxantrone 67 nonmyeloablative 66 Bezielle 66 8mg/kg 66 chemoembolization 66 Leucovorin 66 clodronate 66 cytarabine daunorubicin 66 Xeloda ® 66 liposomal doxorubicin 66 FOLFOX4 alone 66 plus prednisone prednisolone 66 ® lenalidomide 66 Platinol 66 docetaxel chemotherapy 66 fluoropyrimidine 66 intra arterial chemotherapy 66 iniparib BSI 66 induce remission 66 gefitinib Iressa 66 Taxotere chemotherapy 66 Peginterferon alfa 2b 66 Hormone Refractory Prostate Cancer 66 idarubicin 66 hA# 66 antithymocyte globulin 66 NMIBC 66 comparator arm 66 saline placebo 66 alfa 2a 66 ELACYT 66 Anthracycline 66 gemcitabine Gemzar 66 chemotherapy docetaxel 66 HER2 positive cancers 66 surgical debulking 66 fallopian tube carcinoma 66 nonsquamous 66 cranial radiation 66 adalimumab Humira 66 etoposide 66 Vandetanib 66 pegylated IFN 66 resistant hormone refractory 66 metastatic renal 66 NovoTTF 66 nonmetastatic 65 mastectomy chemotherapy 65 methotrexate monotherapy 65 Xelox 65 Velcade bortezomib 65 colorectal liver metastases 65 stage IIIb 65 Amgen Neulasta ® 65 ABVD 65 operable breast cancer 65 Eli Lilly Gemzar 65 KRAS mutant tumors 65 ZOLINZA 65 interferon ribavirin 65 5FU 65 Gliadel Wafer 65 paclitaxel carboplatin 65 humanised monoclonal antibody 65 radiotherapy RT 65 PSMA ADC 65 Vincristine 65 interferon alfa 2b 65 thalidomide Thalomid 65 Fludara 65 mutated K ras 65 Kinoid 65 Naive Patients 65 cisplatin resistant 65 relapsed SCLC 65 metastatic HER2 negative 65 refractory chronic lymphocytic 65 #Gy 65 plus dexamethasone 65 deCODE ProstateCancer TM 65 hormone deprivation 65 abacavir lamivudine 65 metastatic malignant 65 Sanofi Aventis Taxotere 65 refractory metastatic 65 peritoneal carcinomatosis 65 Shark cartilage 65 standard chemotherapy regimen 65 malignant ascites 65 zoledronate 65 Pegasys peginterferon alfa 2a 65 XELOX 65 sargramostim 65 trastuzumab Herceptin 65 nonsmall cell lung cancer 65 cyclophosphamide AC 65 Avastin Tarceva 65 resectable pancreatic cancer 65 ERBITUX Cetuximab 65 imiquimod cream 65 tumor angiogenesis inhibitors 65 metastatic renal cell 65 relapsed ovarian cancer 65 recurrent NSCLC 65 TroVax ® 65 Amgen Neulasta R 65 EndoTAGTM 1 65 receiving highly emetogenic 65 recurrent glioblastoma 65 Aflibercept 65 neurologic progression 65 patients undergoing chemotherapy 65 PEG interferon 65 subcutaneous enoxaparin 65 cyclophosphamide methotrexate 65 Campath alemtuzumab 65 temsirolimus 65 infusional 5-FU/LV 65 Belldegrun 65 plus dacarbazine 65 resected pancreatic cancer 65 FOLFOX chemotherapy 65 Fluorouracil 65 ACTEMRA TM 65 taxane chemotherapy administered 65 sulfonylurea metformin 65 metastatic CRC 65 goserelin 65 refractory ovarian cancer 65 mg/m2 dose 65 imatinib Gleevec 65 Hycamtin 65 external beam radiotherapy 65 non mutated KRAS 65 Panzem R NCD 65 chemosensitizer 65 Natalizumab 65 KRAS wild 65 metastatic colorectal carcinoma 65 dacarbazine chemotherapy 65 pegylated interferon alfa 65 ovarian endometrial 65 contralateral breast 65 achieved CCyR 65 achieved ACR# 65 lenalidomide dexamethasone 65 patients receiving myelosuppressive 65 BEXXAR Therapeutic Regimen 65 chemotherapy FOLFOX 65 zalutumumab 64 complete cytogenetic response 64 BEACOPP 64 Vidaza ® 64 decitabine 64 mutated KRAS 64 bortezomib Velcade R 64 mg m² 64 cetuximab Erbitux R 64 KRAS mutations occur 64 standard chemotherapy regimens 64 dimensional conformal radiation 64 gastrointestinal stromal 64 untreated metastatic pancreatic 64 epirubicin cyclophosphamide 64 antiangiogenic therapy 64 advanced nonsquamous NSCLC 64 castration resistant hormone refractory 64 colorectal lung 64 malignant pleural mesothelioma MPM 64 hormone refractory metastatic prostate 64 mcg albinterferon alfa 2b 64 CIMZIA ™ 64 lenalidomide Revlimid R 64 neoadjuvant chemotherapy 64 galiximab 64 lymphomas leukemias 64 DOXIL 64 plus gemcitabine 64 relapsing remitting MS RRMS 64 mRCC 64 melphalan prednisone 64 peginterferon alpha 2a 64 palifermin 64 premalignant lesion 64 refractory colorectal cancer 64 paclitaxel Taxol 64 EGFR mutation positive 64 intravenous bisphosphonates 64 vinorelbine 64 CIMZIA TM 64 neoadjuvant therapy 64 alkylating agent 64 peritoneal cancer 64 colorectal cancer liver metastases 64 gemtuzumab ozogamicin 64 motesanib 64 mycophenolate mofetil MMF 64 oral chemotherapeutic agent 64 ER CHOP 64 advanced HER2 positive 64 #mg ATC 64 invasive lobular 64 stage IIIB IV 64 CTAP# Capsules 64 Herceptin trastuzumab 64 infusional 64 sorafenib Nexavar ® 64 conventional DMARDs 64 Novartis Afinitor 64 Taxol paclitaxel 64 Temodar temozolomide 64 ZACTIMA 64 differentiated thyroid 64 antimetabolite 64 androgen ablation 64 biologic DMARD 64 HER2 amplified 64 non resectable metastatic 64 erlotinib Tarceva 64 paclitaxel poliglumex 64 FOLPI 64 intravenous cyclophosphamide 64 PROSTVAC VF 64 amoxicillin clavulanate 64 visilizumab 64 chemoradiation 64 docetaxel Injection Concentrate 64 potentially hepatotoxic 64 radiochemotherapy 64 dose dexamethasone 64 anti angiogenic agents 64 weekly subcutaneous injections 64 Thal Dex 64 Doxil 64 platinum refractory 64 #mg BID [001] 64 LHRH receptor positive 64 intraperitoneal therapy 64 gastrointestinal stromal tumor GIST 64 prednisone prednisolone plus 64 TTF therapy 64 Vidaza azacitidine 64 azacitidine 64 Related Anemia 64 Azacitidine 64 Glaxo Tykerb 64 Bisphosphonate 64 TAXOTERE ® 64 fulvestrant 64 sorafenib tablets 64 alendronate Fosamax 64 Stereotactic body 64 ovarian carcinoma 64 liver metastasis 64 Pegintron 64 prostate cancer HRPC 64 Allovectin 7 ® 64 doublet chemotherapy 64 Bacillus Calmette Guerin BCG 64 carmustine 64 K ras mutations 64 azilsartan medoxomil 64 ara C 64 pCR 64 EFAPROXYN 64 MGd 63 KRAS status 63 Mitomycin C 63 ibandronate 63 undergoing hematopoietic stem 63 dexamethasone Decadron 63 MAGE A3 ASCI 63 IFL chemotherapy regimen 63 HERCEPTIN 63 prednisone prednisolone 63 cediranib 63 rituximab Rituxan 63 Capesaris 63 untreated metastatic colorectal 63 vincristine doxorubicin 63 de novo kidney transplant 63 liposomal amphotericin B 63 peginterferon alfa 2a Pegasys 63 trastuzumab Herceptin R 63 azacytidine 63 metastatic hormone refractory 63 Surgical resection 63 epirubicin 63 hepatic metastases 63 treating chronic myeloid 63 Jevtana 63 dose melphalan 63 Ph + acute lymphoblastic 63 basiliximab 63 tumors GIST 63 Pfizer Camptosar 63 Navelbine ® 63 gemcitabine Gemzar ® 63 lapatinib Tykerb 63 aspirin clopidogrel 63 CLL SLL 63 Alkeran 63 Relapsed Refractory Multiple Myeloma 63 sunitinib Sutent 63 Breast conserving 63 myeloablative 63 dose cytarabine 63 Aplidin 63 advanced hepatocellular carcinoma 63 Alessandro Riva 63 aflibercept VEGF Trap 63 previously untreated follicular 63 FOLFOX 63 Copegus ribavirin 63 allogeneic HSCT 63 thalidomide dexamethasone 63 anthracycline chemotherapy 63 refractory Hodgkin 63 pancreatic adenocarcinoma 63 refractory gastrointestinal stromal 63 Interferon beta 63 lumpectomy chemotherapy 63 unresectable HCC 63 raloxifene Evista 63 pegylated interferon alpha 63 pegfilgrastim 63 whose tumors overexpress 63 systemic corticosteroid 63 antiestrogen therapy 63 chemo radiotherapy 63 hematopoietic cancers 63 ALA PDT 63 refractory NSCLC 63 mitoxantrone chemotherapy 63 Arranon 63 Mitoxantrone 63 oxaliplatin Eloxatin 63 nicardipine 63 cabazitaxel 63 cilengitide 63 dalteparin 63 pemetrexed 63 cisplatin vinorelbine 63 visit www.rtanswers.org 63 Novantrone 63 Torisel 63 alpha 2a 63 bi lateral mastectomy 63 minimally symptomatic 63 evaluating tivozanib 63 metastatic kidney 63 pertuzumab 63 non squamous histology 63 Median progression 63 nonnucleoside reverse transcriptase inhibitors 63 FluCAM 63 interferon alfa 63 ChronVac C R 63 postoperative radiotherapy 63 PSA nadir 63 pyridostigmine 63 Trastuzumab Herceptin 63 basal bolus therapy 63 Taxotere ® 63 dacarbazine DTIC 63 forodesine 63 metastatic castration resistant 63 IgM isotype 63 sulfonylurea glimepiride 63 oral Hycamtin 63 ritonavir boosted 63 Neoadjuvant 63 titrated glipizide 63 Fulvestrant 63 induced anemia 63 paricalcitol 63 EGFRIs 63 receiving VICTRELIS 63 Radical prostatectomy 63 TNF alpha antagonist 63 oral ridaforolimus 63 ZACTIMA TM ZD# 63 Acute Myeloid Leukaemia AML 63 Eloxatin oxaliplatin 63 leukemia multiple myeloma 63 certolizumab 63 Oxaliplatin 63 Intravitreal 63 Gemcitabine 63 adjuvant colon cancer 63 idraparinux 63 Neupogen ® 63 Taxotere R 63 chemotherapy 63 Combination therapy 63 allogeneic hematopoietic stem cell 63 lymph node removal 63 dacarbazine 63 heavily pretreated patients 63 HER2 negative 63 TNF blocker therapy 63 Clot busting 63 chemotherapy gemcitabine 63 neoadjuvant 63 breast pancreatic 63 non hodgkin lymphoma 63 corticosteroid dexamethasone 63 refractory chronic myeloid 63 androgen suppression therapy 63 tolterodine ER 63 AstraZeneca Arimidex 63 Ixempra 63 lumbar spine BMD 63 EGFR TKI 63 Patients Receiving 63 R sorafenib tablets 63 CYT# potent vascular disrupting 63 doxorubicin Adriamycin 63 Adjuvant Treatment 63 Temsirolimus 63 EOquin TM phase 63 cranial irradiation 63 Gleevec imatinib 63 neoadjuvant setting 63 malignant pleural mesothelioma 63 Alocrest 62 gadobutrol 62 mild renal insufficiency 62 relapsed ALL 62 chronic HCV genotype 62 Relapsed Refractory 62 Danazol 62 4mg/kg 62 perioperatively 62 R Saizen R 62 HBeAg negative patients 62 T1c 62 adefovir dipivoxil 62 Hurthle cell 62 prostate carcinoma 62 Neulasta ® 62 Tarceva TM 62 locoregional 62 pharmacologically active isomer 62 IV bisphosphonates 62 Her2 positive 62 advanced epithelial ovarian 62 octreotide LAR 62 BRCA deficient 62 dasatinib Sprycel ® 62 neoadjuvant treatment 62 pT3 62 pancreatic lung 62 PASI scores 62 regorafenib 62 FOLFOX regimen 62 Cyclophosphamide 62 androgen deprivation 62 Antitumor Activity 62 Menopausal hormone therapy 62 cisplatin 62 ipsilateral breast 62 mg/m2 IV 62 smoldering myeloma 62 salmeterol fluticasone 62 surgically resectable 62 novel VDA molecule 62 Gemzar ® 62 docetaxel Taxotere R 62 completely resected 62 biliary tract cancer 62 oral rivaroxaban 62 pegylated interferon alfa 2a 62 TEMODAL 62 malignant pheochromocytoma 62 oral diclofenac 62 Bevacizumab 62 Vicinium TM 62 verteporfin 62 Tarceva erlotinib 62 busulfan 62 refractory indolent non 62 eribulin 62 plus 5-FU/LV 62 Decitabine 62 mycophenolic acid 62 HER2 positive tumors 62 sunitinib malate 62 AML acute myeloid 62 mapatumumab 62 flutamide 62 Proleukin 62 invasive lobular carcinoma 62 intraperitoneal chemotherapy 62 ErbB2 positive 62 hepatic tumors 62 Fludara ® 62 metaglidasen 62 CTAP# 62 recombinant erythropoietin 62 chemotherapy Xeloda 62 rituximab refractory 62 Paraplatin 62 vorinostat 62 tenofovir emtricitabine 62 antiandrogen 62 doxazosin 62 nab paclitaxel 62 follicular Non Hodgkin 62 AVODART 62 medically inoperable 62 Hazard Ratio 62 metastatic lung cancer 62 Mg Uk 62 pegylated interferon alpha 2a 62 non squamous 62 pancreatic prostate 62 underwent resection 62 Zometa hazard 62 transaminase elevation 62 lymphoma multiple myeloma 62 hepatorenal syndrome 62 leukemia AML 62 pegylated interferon peg IFN 62 prednisone CHOP 62 steroid dexamethasone 62 immunosuppressive regimen 62 GEMZAR 62 hypofractionated 62 olmesartan 62 humanized interleukin 6 62 Zemplar 62 Cell Lymphoma CTCL 62 FOLFIRI 62 oxycodone CR 62 HuMax EGFr 62 topotecan 62 Cisplatin 62 vinca alkaloids 62 thyroid hormone replacement 62 HER2 expression 62 Gleevec imatinib mesylate 62 tumor histology 62 castrate resistant 62 pain palliation 62 calcineurin inhibitor 62 etanercept Enbrel 62 postmenopausal osteoporotic women 62 alkylating agents 62 leucovorin 62 undergoing peritoneal dialysis 62 baseline neutrophil counts 62 Trastuzumab 62 alvespimycin 62 pegylated interferon alfa 2b 62 antihormonal 62 Glioblastoma Multiforme 62 FIRMAGON 62 oral levofloxacin 62 cytoreductive surgery 62 bleomycin 62 adjunctive placebo 62 thetreatment 62 PegIntron 62 stage IIIA 62 docetaxel Taxotere ® 62 allogeneic stem cell 62 telaprevir dosed 62 efaproxiral 62 alpha1 antitrypsin deficiency 62 TNF Tumor Necrosis Factor 62 colon rectal 62 interferon gamma 1b 62 metastatic dermatofibrosarcoma protuberans DFSP 62 Taxol ® 62 mesalamine granules 62 MabThera Rituxan 62 Roche Actemra 62 HER2 positive breast 62 #F FDG 62 PEGylated Fab fragment 62 H. pylori eradication 62 estrogen receptor progesterone receptor 62 argatroban 62 teriflunomide 62 Targretin capsules 62 radioiodine therapy 62 EUFLEXXA R 62 cytotoxic chemotherapy 62 intestinal polyps 62 Stage IIIb 62 #.#ng/ml 62 Rituxan rituximab 62 bevacizumab Avastin ® 62 docetaxel prednisone 62 heavily pretreated 62 Glioblastoma multiforme GBM 62 nilotinib Tasigna ® 62 MIRAPEX ER 62 Pegylated interferon 62 systemic anaplastic large 62 imexon 62 vinorelbine tartrate 62 curative resection 62 assessing T DM1 62 pegylated liposomal doxorubicin PLD 62 Navelbine 62 plus methotrexate 62 chemo therapy 62 metastatic malignant melanoma 62 enzastaurin 62 Torisel temsirolimus 61 cytotoxic therapy 61 autologous transplants 61 genotypic resistance 61 bendamustine ifosfamide 61 thymic carcinoma 61 non metastatic resectable 61 vinca alkaloid 61 pegaptanib 61 Accelerated Partial Breast Irradiation 61 Papillary 61 Zorbtive TM 61 cinacalcet 61 receiving XGEVA 61 Bayer Nexavar 61 PSADT 61 antiresorptive 61 3D conformal radiation 61 Celgene Revlimid 61 autoantibody positive 61 recovery CRp 61 ovarian suppression 61 gemcitabine 61 rFSH 61 skeletal metastases 61 GW# [003] 61 smoldering multiple myeloma 61 levosimendan 61 chemoresistant 61 azathioprine 61 Melphalan 61 oral hypoglycemic agent 61 Mg Usa 61 Cetuximab 61 taxane resistant 61 localized prostate 61 mCi 61 bladder ovarian 61 BENICAR HCT 61 Femara letrozole 61 Acute myeloid leukemia 61 advanced medullary thyroid 61 prospectively stratified 61 dexrazoxane 61 Pegasys plus Copegus 61 chemotherapeutic regimens 61 bortezomib refractory 61 systemic immunosuppressive 61 p#HER# positive 61 advanced adenomas 61 epoetin alpha 61 rHuEPO 61 q8h 61 daily subcutaneous injections 61 radiotherapy chemotherapy 61 papillary renal cell carcinoma 61 nondiabetic patients 61 LHRH analogues 61 GVAX Immunotherapy 61 injected subcutaneously 61 AROMASIN 61 chemotherapy hormonal therapy 61 gastrointestinal stromal tumors GIST 61 SPRYCEL ® 61 unresectable 61 Pegylated Liposomal Doxorubicin 61 Interferon alfa 61 allogeneic transplant 61 #mg q8h 61 docetaxel 61 oral antidiabetic medication 61 methotrexate therapy 61 gastric corpus 61 inhaled fluticasone 61 metastatic lymph nodes 61 Inhaled nitric oxide 61 Helicobacter pylori eradication 61 cancerous nodules 61 deletion 5q 61 cisplatin carboplatin 61 epoprostenol 61 YONDELIS 61 APTIVUS R 61 Adjuvant therapy 61 ribavirin RBV 61 TRAIL R1 61 lumbar disk herniation 61 Dual Opioid 61 Letairis ambrisentan 61 Lung transplantation 61 Surgical excision 61 Squamous 61 vandetanib 61 bortezomib Velcade 61 exemestane Aromasin 61 endometrial hyperplasia 61 ANCA associated 61 Follicular Lymphoma 61 Cremophor 61 basal cell skin 61 progesterone receptor negative 61 antirheumatic 61 GP IIb IIIa inhibitors 61 bone marrow reticulin deposition 61 imatinib therapy 61 antiretroviral naïve 61 sorafenib Nexavar R 61 care regimens CCR 61 adjuvant trastuzumab 61 tamoxifen citrate 61 Genentech Tarceva 61 baminercept 61 gastrointestinal stromal tumors 61 Host Disease 61 cancer mCRC 61 mCRC patients 61 Chemoradiation 61 Pertuzumab 61 nitroprusside 61 VANTAS ® 61 gastroesophageal junction 61 antibody MAb 61 ovarian breast 61 Viread Emtriva 61 metastatic CRPC 61 recurrent GBM patients 61 refractory myeloma 61 abdominal irradiation 61 aliskiren amlodipine 61 bevacizumab Avastin 61 Vitaxin 61 cyclophosphamide 61 metastatic carcinoma 61 unresectable locally advanced 61 axillary dissection 61 cetuximab Erbitux 61 bacillus Calmette Guerin 61 evaluating picoplatin 61 IFN beta 61 fluvastatin 61 Cojocaru correspondent 61 Ivanhoe Newswire Patients 61 ovarian lung 61 mg TID 61 cetuximab Erbitux ® 61 noninvasive outpatient 61 candesartan cilexetil 61 reduce serum phosphate 61 Amrubicin 61 STELARA ® 61 RhuDex TM 61 Lenalidomide 61 PROCHYMAL 61 immunomodulatory agents 61 TransVax 61 VIDAZA 61 tamoxifen Nolvadex 61 naïve HCV 61 radiation therapy SBRT 61 q#h 61 EGFR expressing 61 induced neuropathy 61 metastatic castrate resistant 61 abiraterone acetate 61 Patients Treated With 61 metastatic renal cell carcinoma 61 intravenous immunoglobulin 61 cis retinoic acid 61 histologically proven 61 HGS ETR1 mapatumumab 61 colorectal adenoma 61 radiolabeled TM# 61 elacytarabine 61 deep venous thromboses 61 removed laparoscopically 61 cardiotoxic 61 cyclophosphamide Cytoxan 61 Abiraterone acetate 61 biochemical recurrence 61 Ribavirin causes 61 Pharmacokinetics PK 61 recurrent epithelial ovarian 61 Xeloda capecitabine 61 advanced carcinoid 61 fludarabine 61 BCG refractory 61 radiofrequency ablation RFA 61 rindopepimut 61 pazopanib 61 neratinib 61 androgen suppression 61 myelodysplastic myeloproliferative diseases 61 blood clot dissolving 61 biliary cancer 61 ANAVEX #-# [001] 61 neutrophil counts 61 fluticasone salmeterol 61 Intravenous immunoglobulin 61 basal cell carcinoma BCC 61 progressive metastatic prostate 61 Epirubicin 61 Prednisone Against Refractory 61 achieved PASI 61 rituximab Rituxan ® 61 Refractory Hodgkin Lymphoma 61 FOLFIRINOX 61 autologous hematopoietic stem cell 61 lipid lowering therapies 61 #I TM# 61 Soft Tissue Sarcoma 61 hematological cancers notably 61 ritonavir boosted atazanavir 61 weekly intravenous infusions 61 imatinib Gleevec ® 61 Ophena TM 61 FASLODEX 61 platelet inhibitor 61 Degarelix 61 VELCADE melphalan 61 CYPHER Stent 61 #mg/m# [002] 61 FLT3 ITD 61 Cytarabine 61 Aptivus ® 61 YERVOY 61 Sandostatin R 61 IMiDs 61 MDS AML 61 Proxinium TM 61 FOSRENOL ® 61 hsCRP levels 61 allogeneic SCT 61 statin monotherapy 61 efavirenz EFV 61 Newly Diagnosed Multiple Myeloma 61 leukemia APL 61 #.#mg/dL 61 zidovudine lamivudine 61 pomalidomide 61 intravenous bolus injection 61 mercaptopurine 61 Basal Cell 61 alemtuzumab Campath 61 inecalcitol 61 patients undergoing noncardiac 61 chronic hemodialysis 61 PegIFN RBV 61 plus fludarabine 61 anticoagulants blood thinners 61 PLX STROKE targeting 61 Ishak fibrosis score 60 chronic myeloid 60 GRNOPC1 contains 60 R Bortezomib 60 aromatase inhibitor therapy 60 AVASTIN